Sumatriptan Chemical Structure (Sumatriptan Nasalspray Spl Graphic 01)
Sumatriptan Spray
Product Images NDC 71921-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 71921-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Florida Pharmaceutical Products, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Estimated Probability Of Initial Headache Response Within 120 Minutes (Sumatriptan Nasalspray Spl Graphic 02)
This appears to be a graph showing the results of a study or experiment involving various doses of a drug (possibly a painkiller) versus a placebo, over a period of time up to 30 or 40 minutes after initial dosage. The drug is referred to in two doses, 4.5mg and 20mg, and is identified with the letter "g" in both instances. The placebo is labeled as "+ placebo." The graph shows the effectiveness of each dosage level over time, with the drug outperforming the placebo. The lower portion of the graph includes labels for different time intervals (0-15, 15-30, etc.) and a scale from 0 to 100%. The label "E" appears to be a typo or artifact of the process.*
Figure 2. Probability Of Patients Needing Second Dose Or Additional Medication (Sumatriptan Nasalspray Spl Graphic 03)
Figure A (Sumatriptan Nasalspray Spl Graphic 04)
Figure B (Sumatriptan Nasalspray Spl Graphic 05)
Figure C (Sumatriptan Nasalspray Spl Graphic 06)
Figure D (Sumatriptan Nasalspray Spl Graphic 07)
Figure E (Sumatriptan Nasalspray Spl Graphic 08)
Figure F (Sumatriptan Nasalspray Spl Graphic 09)
Imitrex Nasal 20 mg 6 Count Carton (Sumatriptan Nasalspray Spl Graphic 10)
This is a product description of Sumatriptan Nasal Spray, USP. Each unit contains 20g of sumatriptan with a dose of 0.1 L for intranasal use only. It comes with 6 nasal spray units. The usual dosage is indicated in the prescribing information, and it should be stored between 2°C and 30°C. The product is manufactured for Florida Pharmaceutical Products, LLC, and made in Canada. The inactive ingredients include monobasic potassium phosphate, anhydrous dibasic sodium phosphate USP, succinic acid NF, sodium chloride USP, and water for injection USP.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
